drugset / Trial / NCT04996966

Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury

NCT04996966

Phase 1 Unknown 16 enrolled Shanghai East Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is an exploratory clinical study to observe the improvement of lung function before and after the treatment by human umbilical cord-derived mesenchymal stem cells, and the purpose is to evaluate the safety and effectiveness of human umbilical cord-derived mesenchymal stem cells on non-cardiac surgery-induced lung injury in patients with ischemic heart disease. The study is a randomized parallel controlled study. Patients receive a review of which main content includes symptom improvement, lung function improvement, and adverse events.

Timeline

Start
2021-08-01
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Umbilical Cord-derived Mesenchymal Stem Cells Cell therapy 1e+06 cells/kg Intravenous